Blog

DEEP DIVE: Therapeutics 
Harnessing the power of science; what’s next for biopharma as it searches for the next breakthrough therapeutic

Moderator: Rivka Jungreis, Teva Pharmaceuticals, Parsippany, NJ

Part 1 - 2:00 - 3:15 pm

Emergence of the Medical Device as an Important Aspect of Pharamceutical/Biologic Patent Strategy
Ricardo Moran, Schwegman Lundberg & Woessner, Minneapolis, MN

Creative Uses of AI/Machine-Learning in the Pharma/Bio Field
Andrew Noble, Mauriel Kapouytian Woods LLP, New York, NY

Patents vs. Trade Secrets in Biotech and Pharma: Navigating the Quagmire
Raija Horstman, Crowell Moring, Los Angeles, CA

Trademark - The Power of Branding in Bio/Pharma: Using Trade Dress for Product Life-Cycle Management
Lynn Jordan, Kelly IP, Washington, DC

Break - 3:15 - 3:30 pm

Part 2 - 3:30 - 4:30 pm

Navigating Privacy Compliance for Therapeutics Products and Services
Neelofer Shaikh, Covington & Burling LLP,  Los Angeles, CA

Public-Private Partnerships and and the implications of Bayh-Dole
Don Ware, Foley Hoag, Boston, MA

Creative IP Strategies in the Pharma/Bio Space -Thinking Outside the Box
Tom Irving, Finnegan, Washington, DC

Speakers

• Ware, Donald

  Foley Hoag LLP | Partner & Co-Chair of IP Litigation Group

  Donald Ware is a partner and co-chair of the IP Litigation Group in the Boston office of Foley Hoag LLP. His practice focuses on patent litigation, licensing, and counseling. Don has decades of experience in life sciences patent and inventorship disputes, in which he represents global biopharmaceutical companies, universities, and research institutions. He also represents universities and their licensees in Bayh-Dole matters, including Bayh-Dole march-in proceedings.
• Irving, Thomas L.

  The Marbury Law Group, PLLC | Partner

  Tom Irving has more than 46 years of experience in the field of intellectual property law. His practice includes America Invents Act (AIA) post-grant proceedings, due diligence, counseling, patent prosecution, and reissue and reexamination. He counsels clients on a wide range of mainly pharmaceutical matters, including pre-litigation, Orange Book listings of patents covering FDA-approved drugs, infringement issues, enforceability and validity analysis.
• Jordan, Lynn M.

  Kelly IP | Founding Partner

  For the past 30 years, Lynn Jordan has devoted herself to representing clients in all aspects of trademark law, from selection of marks through federal court appeals. She is particularly adept at helping clients understand the business and legal risks associated with the adoption, use, and registration of trademarks. Lynn has handled countless clearance, prosecution, and enforcement matters, and regularly speaks and writes on a variety of trademark topics.
• Noble, Andrew

  Mauriel, Kapoutian Woods LLP | Attorney

  As a registered patent attorney in New York, ANDREW NOBLE regularly handles patent preparation, prosecution, and related complex U.S. Patent Office proceedings. He is very experienced in managing large-scale domestic and international patent portfolios. He is also very experienced in counseling clients on intellectual property and technology services issues arising in complex transactions, like private equity, mergers and acquisitions, public and private offerings, and licensing programs. In addition, Andrew has tried patent matters before federal courts.
• Moran, Ricardo

  Schwegman Lundberg & Woessner | Principal

  Ricardo Moran is a registered patent attorney practicing intellectual property law with an emphasis on small-molecule pharmaceuticals and agrochemicals and their formulations; imaging agents; and materials science. Dr. Moran’s practice focuses on chemical and pharmaceutical intellectual property law, including pharmaceutical patent litigation; preparation and prosecution of patent applications; infringement, validity, patentability, and due diligence analyses and opinions; and counseling of clients in a wide range of aspects of intellectual property law.
• Shaikh, Neelofer

  Covington & Burling LLP | Attorney

  Neelofer Shaikh is an attorney in Covington & Burling LLP’s Los Angeles office and a member of the Data Privacy and Cybersecurity Practice Group. She advises clients on a wide range of privacy, cybersecurity, and consumer protection issues, including privacy and cybersecurity obligations under U.S. federal and state laws, cybersecurity preparedness and incident response, and defending against regulatory inquiries and class-action litigation.
• Jungreis, Rivka

  Teva Pharmaceuticals USA | Patent Litigator

  Rivka Jungreis is a patent litigator at Teva Pharmaceuticals USA. She handles an extensive docket of pharmaceutical patent litigation involving Teva’s generic, branded, biologic, and biosimilar products. Rivka also advises the company on a variety of trade secret, FDA regulatory, and antitrust issues in the pharma space.
• Horstman, Raija

  Crowell & Moring | Counsel

  Raija Horstman is an experienced litigator focused in multiple areas of complex commercial litigation, including trade secrets, false advertising, unfair competition, copyright infringement, trademark infringement, and consumer and employment class actions. Raija is a counsel in the Los Angeles office of Crowell & Moring.